For: | Yamashiro H, Morii N. Abemaciclib-induced lung damage leading to discontinuation in brain metastases from breast cancer: A case report. World J Clin Cases 2023; 11(35): 8425-8430 [PMID: 38130622 DOI: 10.12998/wjcc.v11.i35.8425] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i35/8425.htm |
Number | Citing Articles |
1 |
Yumi Nozaki, Minori Yamamuro, Noriyoshi Tanaka, Nobuyuki Kamo, Juichiro Konishi. Long-Term Control of Breast Cancer Brain Metastases Using Abemaciclib and Letrozole Combination Therapy: A Case Report. Cureus 2025; doi: 10.7759/cureus.79805
|
2 |
Qiongwen Zhang, Xi Yan, Ting-Lun Tian, Xin Wu. Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1381478
|
3 |
|
4 |
Maria Rosaria Valerio, Calogero Cipolla, Martina Greco, Chiara Mesi, Francesca Modica, Vittorio Gebbia, Giuseppa Scandurra, Daniela Sambataro. Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251317847
|